The newly developed Insulin Simulator is an online interactive tool that lets healthcare professionals (HCPs) create and evaluate a variety of insulin regimens for a diverse set of hypothetical patients with varied characteristics. The Insulin Simulator is designed to help HCPs understand the impact of different insulin doses and types on blood glucose values.

Dr. Diana Isaacs will provide an in-person demonstration of the Insulin Simulator.

About Dr. Isaacs:


Endocrine Clinical Pharmacist and Remote Monitoring Program Coordinator at the Cleveland Clinic

  • Holds board certifications in pharmacotherapy, ambulatory care, and advanced diabetes management
  • Serves on the Professional Practice Committee of the American Diabetes Association, as well as the National Board for the Association of Diabetes Care& Education Specialists (ADCES)
  • Is an ADCES and American College of Clinical Pharmacy fellow
  • Advocates for access to the latest technologies and therapeutics for all people with diabetes and speaks on diabetes-related topics nationally and internationally​

​ VV-MED-121480 © 2022 Lilly USA, LLC. All Rights Reserved



This video provides an overview of biosimilar and interchangeable scientific concepts and US regulatory approval process with a focus on insulin glargine products in the US.​

MTI-SocialMediaPosts-21LLY065-L-with copy (2).jpg


Dr. John Anderson and Teresa Pearson will discuss strategies to help overcome some of the barriers that healthcare professionals (HCPs) and people with type 2 diabetes (T2D) encounter when initiating MTI, as well as provide tools to:

  • Identify the appropriate person with T2D for MTI>
  • Initiate MTI and use titration algorithms
  • Understand the follow-up required for people who are new to MTI ​​​


Teresa Pearson and Dr. Stephen Ponder will use a patient case study to discuss the benefits of using time in ranges (TIRs) to assess glycemic control: 

  • Review the metrics for assessing glycemic control, which include PPG and TIRs and their link to A1c
  • Highlight TIRs as CGM-derived metrics that provide actionable information for assessing glycemic control and focus the patient/provider conversation
  • Demonstrate the potential of TIRs as a useful tool to help patients and healthcare professionals guide diabetes management and treatment
  • Reference established guidelines and identify helpful resources and tips developed by diabetes care and education specialists


​​Tip Sheets for People Living with Diabetes

NEW The Importance of Using Medicine Early in the Management of Type 2 Diabetes​
NEW What to Know About Medicines That Work Like Incretins in the Gut to Treat T2D​​​

NEW Building Confidence with Connected Insulin Pens and Platforms​
English | ​Spanish
NEW ​Introduction to Connected Pens and Platforms
English | ​Spanish​
Understanding Side Eff​ects for Incretin-Based Therapies
English​ | ​Spanish
Weight and Type 2 Diabetes: What’s the Link?​
English​ | ​Spanish
Managing Blood Suga​r with Time-in-Range
English​ | Spanish

Managing Low Blood Sugar in Adults
English | Spanish

Managing Low Blood Sugar in Children
English | Spanish

Using Faster Acting Insulin in your Pump
English | Spanish​

Tip Sheets for Healthcare Providers

The Role of Insulin Smart Pens
Englis​h | Spanish

Using Smart Pen Platform Data to Inform Insulin Management​
English​ | Spanish​​
NEW - Biosimilar and Interchangeable Insulins - What Clinicians Need to Know​

NEW The Huddle - Podcast: Helping Clients/Patients Meet Targets with GIP/GLP-1 Receptor Agon​ists

NEW Forefront Ep 4: Improving Mealtime Insulin Outcomes with Connected Health Tools

Brought to you by Eli Lilly and Company.​


The content and information contained on this site is being provided as a convenience and for informational purposes only. The posting of sponsored content on this site should not be considered an endorsement or recommendation of the sponsor's products, services, policies, or procedures by the American Association of Nurse Practitioners (AANP). The information and opinions expressed on this page are those of the paid sponsors and do not necessarily reflect the view of the AANP. AANP is not responsible for the content of third-party websites linked from this page; moreover, any links on this page to third-party websites where goods or services are advertised are not endorsements or recommendations by AANP of the third-party sites, goods, or services.